India "misinterpreted" WHO on vax plants; Germany checks cheap AIDS drug import scheme;

> A parliamentary panel in India says it was "abundantly clear" that the decision to suspend the licenses of three public vaccine-making plants was based on "a major misconception and misinterpretation" of WHO's assessment of them. Story

> German police are investigating pharma distributors suspected of importing cheap AIDS vaccines from Africa and selling them at inflated prices. Story

> Japan has suspended vaccines made by Pfizer and Sanofi-Aventis while regulators investigate the deaths of four children. Item

> Giant robots count and process medications at the UC San Francisco Medical Center. Article

> "The operating environment for pharma is worsening rapidly," says Morgan Stanley, as it downgrades the multinational pharmaceutical companies in Europe. Story

> India may be facing a shortage of professionals in the pharma outsourcing sector. Article

> WuXi PharmaTech will build and operate a cGMP-compliant 25,000-square-foot facility in Shanghai to store and test stability samples for Bristol-Myers Squibb. BMS-WuXi release

> Pharma is among Canadian manufacturing sectors investing in distribution facilities to meet retailers' daily replenishment requirements. Story

> Colorado-based Tolmar has selected Pilgrim Software's Risk, Compliance and Quality Management solution. Pilgrim Software release

> Merck KGaA has appointed Friedhelm Felten head of corporate procurement with responsibility for global purchasing activities. Story

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.